65 related articles for article (PubMed ID: 6543907)
1. Electrodiagnostic tests in the detection of malignant hyperthermia.
Eng GD; Becker MJ; Muldoon SM
Muscle Nerve; 1984 Oct; 7(8):618-25. PubMed ID: 6543907
[TBL] [Abstract][Full Text] [Related]
2. [Screening tests for malignant hyperthermia susceptibility].
Krivosic-Horber R; Adnet P
Ann Fr Anesth Reanim; 1989; 8(5):444-56. PubMed ID: 2560612
[TBL] [Abstract][Full Text] [Related]
3. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia.
Britt BA; Scott EA
Anesth Analg; 1986 Feb; 65(2):171-5. PubMed ID: 3942305
[TBL] [Abstract][Full Text] [Related]
4. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
5. Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
Quinlan JG; Wedel DJ; Iaizzo PA
Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846
[TBL] [Abstract][Full Text] [Related]
6. [Malignant hyperthermia in Austria. II. A comparison of the results of diagnostic test procedures].
Mauritz W; Hackl W; Sporn P; Graf M; Sluga E; Steinbereithner K
Anaesthesist; 1988 Jul; 37(7):425-31. PubMed ID: 3414955
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
8. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
9. Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
Gallant EM; Godt RE; Gronert GA
J Pharmacol Exp Ther; 1980 Apr; 213(1):91-6. PubMed ID: 6965721
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
Allen GC; Larach MG; Kunselman AR
Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
[TBL] [Abstract][Full Text] [Related]
11. Electromyographic evaluation of malignant hyperthermia-susceptible pigs.
Steiss JE; Bowen JM; Williams CH
Am J Vet Res; 1981 Jul; 42(7):1173-6. PubMed ID: 7271037
[TBL] [Abstract][Full Text] [Related]
12. Sustained focal effects of low-dose intramuscular succinylcholine.
Walker FO; Scott GE; Butterworth J
Muscle Nerve; 1993 Feb; 16(2):181-7. PubMed ID: 8429843
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylase ratio and susceptibility to malignant hyperthermia.
Traynor CA; Van Dyke RA; Gronert GA
Anesth Analg; 1983 Mar; 62(3):324-6. PubMed ID: 6299136
[TBL] [Abstract][Full Text] [Related]
14. A minimally invasive metabolic test with intramuscular injection of halothane 5 and 6 vol% to detect probands at risk for malignant hyperthermia.
Schuster F; Gardill A; Metterlein T; Kranke P; Roewer N; Anetseder M
Anaesthesia; 2007 Sep; 62(9):882-7. PubMed ID: 17697213
[TBL] [Abstract][Full Text] [Related]
15. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
Glauber V; Ben Abraham R; Zweig A; Perel A
Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
[TBL] [Abstract][Full Text] [Related]
16. Carpal tunnel syndrome: comparison of the compound muscle action potentials recorded at the thenar region from ulnar and median nerve stimulation.
Wee AS
Electromyogr Clin Neurophysiol; 2006; 46(2):123-6. PubMed ID: 16796002
[TBL] [Abstract][Full Text] [Related]
17. Failure of the tourniquet-twitch test as a diagnostic or screening test for malignant hyperthermia.
Britt BA; Scott EA; Kleiman A; Jones P; Steward DJ
Anesth Analg; 1986 Oct; 65(10):1047-50. PubMed ID: 3752552
[TBL] [Abstract][Full Text] [Related]
18. TENS-induced pain control in a malignant hyperthermia-susceptible patient.
Stenberg W
Anesth Prog; 1994; 41(4):100-1. PubMed ID: 8934960
[TBL] [Abstract][Full Text] [Related]
19. The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
Schuster F; Schöll H; Hager M; Müller R; Roewer N; Anetseder M
Anesth Analg; 2006 Feb; 102(2):468-72. PubMed ID: 16428544
[TBL] [Abstract][Full Text] [Related]
20. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
Sudo RT; Nelson TE
J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
